Paul M. Silva

Insider Reports History

Entity
Individual
Location
C/O Vertex Pharmaceuticals Incorporated, 130 Waverly St, Cambridge, MA
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul M. Silva:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rapport Therapeutics, Inc. Director Stock Option (Right to Buy) 29.8K Nov 7, 2024 Direct
Nurix Therapeutics, Inc. Director Director Stock Option (right to buy) 25K May 20, 2024 Direct

Insider Reports Filed by Paul M. Silva

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RAPP Rapport Therapeutics, Inc. Nov 7, 2024 1 $0 4 Nov 7, 2024 Director
RAPP Rapport Therapeutics, Inc. Nov 7, 2024 0 $0 3 Nov 7, 2024 Director
NRIX Nurix Therapeutics, Inc. May 20, 2024 1 $0 4 May 20, 2024 Director
NRIX Nurix Therapeutics, Inc. May 4, 2023 1 $0 4 May 4, 2023 Director
NRIX Nurix Therapeutics, Inc. May 5, 2022 1 $0 4 May 6, 2022 Director
NRIX Nurix Therapeutics, Inc. Oct 1, 2021 1 $0 4 Oct 4, 2021 Director
NRIX Nurix Therapeutics, Inc. Oct 1, 2021 0 $0 3 Oct 1, 2021 Director